Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
Once a new sensor is inserted by your health care professional and paired with the transmitter using the Eversense® App, it will start the 24-hour warm-up phase. Once the 24-hour warm-up phase is completed, you will begin the Initialization Phase.
Initialization Phase (after 24-hour Warm-Up Phase)
During this phase, 4 finger stick blood glucose meter tests are required.
- The 4 calibration tests must be spaced 2 to 12 hours apart, and all 4 tests must be completed within a 36 hour period.
- 1st calibration = 24 hours after sensor insertion.
- 2nd calibration = 2 to 12 hours after 1st successful calibration.
- 3rd calibration = 2 to 12 hours after 2nd successful calibration.
- 4th calibration = 2 to 12 hours after 3rd successful calibration.
- Glucose readings will start displaying in the app a few minutes after the 2nd calibration is successfully completed.
The sensor requires a 24-hour Warm-Up Phase to stabilize in your body before glucose values will be collected by the smart transmitter. During the Warm-Up Phase, you do not need to wear the smart transmitter. If you decide to wear the smart transmitter over the sensor during this time, you will receive a message on the app indicating the Warm-Up Phase is in progress. Once the Warm-Up Phase is complete, turn ON the smart transmitter and place it over the sensor with the Eversense® adhesive patch. The system will prompt you to calibrate using the app.
The Eversense® 365 CGM System provides readings within 40 – 400 mg/dL range every 5 minutes.
Follow the steps to creating your account in the Eversense 365® App and activating your account. Once you Log In, follow the steps to Pair your transmitter, link your sensor, and complete warm-up and initialization phase.
You can go to the System Set Up menu at any time as well. Main Menu > System Set Up
The Eversense® 365 Smart Transmitter provides on-body vibe alerts even when the connection between the mobile device and the smart transmitter is lost (as long as your smart transmitter battery is not depleted).
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
MKT-001692 Rev 1
Call My Eversense Specialist Now
Schedule a Call